Download Internet Explorer 8 or Firefox 3 now!
Susan Morpeth
kilifi [dot] kemri-wellcome [dot] org Research
Dr Susan Morpeth is a Clinical Microbiologist and Infectious Diseases Physician, who joined the KEMRI-Wellcome Trust Research Programme in January 2009. She is interested in pneumonia, invasive bacterial disease, antimicrobial susceptibility testing, molecular diagnostics, quality assurance and capacity-building. Susan is about to start a PhD on understanding the spread of pneumococcal infection from healthy carriage to invasive disease. As well as running the microbiology laboratory in Kilifi and acting as Biosafety officer for the programme, Susan travels regularly to Thika to advise on the microbiology laboratory in the Pneumococcal Conjugate Vaccine Impact Study project there. In Kilifi, Susan has been involved in the setting up of the category 3 Tuberculosis laboratory, and is now expanding the programme's molecular laboratory capacity into bacteriology.
Collaborations
Publications
Feikin DR, Jagero G, Aura B, Bigogo GM, Oundo J, Beall BW, Karani A, Morpeth S, Njenga KM and Breiman R. High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya. BMC Infectious Diseases 2010, 10:186.
Morpeth SC, Ramadhani HO, Crump JA. Invasive non-Typhi Salmonella disease in Africa. Clin Infect Dis. 2009 Aug 15;49(4):606-11.
Tillekeratne LG, Thielman NM, Kiwera RA, Chu HY, Kaale L, Morpeth SC, Ostermann J, Mtweve SP, Shao JF, Bartlett JA, Crump JA. Morbidity and mortality among a cohort of HIV-infected adults in a programme for community home-based care in the Kilimanjaro Region of Tanzania (2003-2005). Ann Trop Med Parasitol. 2009 Apr;103(3):263-73
Morpeth SC, Thielman NM, Ramadhani HO, Hamilton JD, Ostermann J, Kisenge PR, Shao HJ, Reller LB, Itemba DK, Sam NE, Bartlett JA, Shao JF, Crump JA. Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):585-91.
Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernández-Hidalgo N, Dickerman S, Bouza E, del Río A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med. 2007 Dec 18;147(12):829-35.
Ramadani HO, Thielman NM, Landman KZ, Ndosi EM, Gao F, Kirchherr JL, Shah R, Shao HJ, Morpeth SC, McNeill JD, Shao JF, Bartlett JA, Crump JA. Predictors of incomplete adherence, virologic failure and viral drug resistance among HIV-1-infected persons receiving antiretroviral therapy in Tanzania. Clin Infect Dis. 2007 Dec 1;45(11):1492-8.
Morpeth SC, Crump JA, Shao HJ, Ramadhani H, Kisenge P, Moylan C, Naggie S, Landman K, Sam N, Itemba D, Shao J, Bartlett J, Caram L, Thielman NM. Predicting CD4 Lymphocyte Count < 200/mm3 in an HIV-1-Infected African Population. AIDS Res Hum Retroviruses. 2007 Oct;23(10):1230-6.
Morpeth SC, Thielman NM. Diarrhea in patients with AIDS. Curr Treat Options Gastroenterol. 2006 Feb;9(1):23-37.
Morpeth SC, Chambers ST, Gallagher K, Frampton C, Pithie A. Lower limb cellulitis: features associated with length of hospital stay. J Infect. 2006 Jan;52(1):23-9.
Chambers ST, Morpeth SC, Laird HK. Campylobacter fetus prosthetic hip joint infection: successful management with device retention and review. J Infect. 2005 Apr;50(3):258-61.